STOCK TITAN

Biolargo Stock Price, News & Analysis

BLGO OTC Link

Company Description

BioLargo, Inc. operates as a cleantech and life sciences innovator focused on developing and commercializing environmental technologies. The company engineers products and systems that address critical environmental challenges including PFAS contamination in water supplies, advanced water and wastewater treatment, industrial odor and volatile organic compound control, air quality improvement, energy storage, and infection control in medical settings.

The company's business model centers on inventing or acquiring novel technologies, developing them into marketable products, and expanding commercial reach through licensing agreements and strategic channel partnerships. This approach allows BioLargo to maximize the impact of its innovations while preserving capital and leveraging partner expertise in manufacturing and distribution.

Water Treatment Technologies

BioLargo's water treatment division focuses on PFAS removal from contaminated water sources. The company has developed the BioLargo AEC (Aqueous Electrostatic Concentrator), which uses electrolysis to extract PFAS molecules from water and deposit them onto proprietary membranes. This technology operates with minimal electricity consumption and requires no input chemistry, differentiating it from traditional carbon filtration systems. The AEC system demonstrates effectiveness in removing PFAS while producing less contaminated waste compared to conventional treatment methods, resulting in lower waste disposal costs for operators.

The Advanced Oxidation System represents another core water treatment technology in the company's portfolio. This platform treats water by removing contaminants and providing disinfection capabilities. Applications span industrial wastewater treatment, municipal water treatment, and various other sectors requiring advanced water purification.

Energy Storage Solutions

Through its battery technology subsidiary, BioLargo develops liquid-sodium battery systems designed for long-duration energy storage applications. The Cellinity battery technology avoids the thermal runaway risks associated with lithium-based systems and eliminates dependency on rare earth minerals and toxic chemicals. The company positions these batteries as suitable for grid stabilization, renewable energy storage, municipal power systems, data centers, and electric vehicle charging infrastructure.

BioLargo employs a unique commercialization strategy for its battery technology, contemplating a joint venture model where partners engage the company to engineer, design, and build manufacturing facilities. In exchange for licensing rights and ongoing royalties on sales, partners gain the ability to produce batteries locally, creating employment opportunities and economic development in their regions while accessing specific industrial markets.

Consumer and Medical Products

The company's consumer products division markets pet odor elimination products under the Pooph brand. These products utilize proprietary odor-control technology and are distributed through major retail channels including e-commerce platforms and brick-and-mortar stores. The consumer products segment demonstrates the company's ability to translate laboratory technologies into mass-market applications.

In the medical technology sector, BioLargo has developed Bioclynse, a wound irrigation solution intended for use during surgical procedures. The product employs copper and iodine technology engineered to be non-cytotoxic and non-sensitizing to tissue. Bioclynse is designed to be effective against biofilms while maintaining sustained antimicrobial efficacy without requiring rinse-out after application. The company has pursued distribution partnerships with established medical device companies to bring this product to market.

Corporate Structure and Operations

BioLargo operates through multiple business segments that address different market opportunities. ONM Environmental focuses on industrial and municipal water treatment solutions. Clyra Medical develops medical device technologies for infection control. BioLargo Energy Technologies (BETI) advances the company's battery and energy storage initiatives. BioLargo Equipment Solutions & Technologies provides engineering services and equipment. BLEST concentrates on specific environmental applications, and BioLargo Canada manages Canadian market operations.

The company maintains an extensive patent portfolio developed through sustained research and development activities. These intellectual property assets underpin the company's technology licensing business model and provide competitive barriers in its target markets. BioLargo also offers full-service environmental engineering capabilities, allowing it to design and implement treatment systems for clients while generating recurring service revenue.

Industry Focus and Applications

BioLargo serves multiple industries with environmental challenges. Municipal water utilities represent a significant market for PFAS treatment and general water purification systems. Industrial clients require wastewater treatment, odor control, and air quality management for manufacturing facilities. The healthcare sector utilizes infection control technologies for surgical and wound care applications. Energy companies and utilities seek energy storage solutions for grid management and renewable integration.

The company's technologies address regulatory pressures facing many of these industries, particularly concerning PFAS contamination and water quality standards. As environmental regulations evolve and become more stringent, demand for effective treatment technologies continues to expand across BioLargo's target markets.

BioLargo positions itself at the intersection of environmental protection, public health, and sustainable technology development. The company's engineering-driven approach combines scientific innovation with practical commercial applications, aiming to deliver environmental solutions that meet both technical performance requirements and economic viability for customers across diverse sectors.

Stock Performance

$—
0.00%
0.00
Last updated:
-9.94 %
Performance 1 year
$71.1M

Financial Highlights

$776
Revenue (TTM)
$6,707
Operating Cash Flow
$372
Gross Profit (TTM)

Upcoming Events

JAN
01
January 1, 2026 - April 30, 2026 Product

ViaCLYR market launch

Nationwide market launch of ViaCLYR via Advanced Solution distribution
JAN
01
January 1, 2026 - December 31, 2026 Financial

Clyra commercial revenue

Company expects meaningful Clyra (ViaClyr) commercial revenue in 2026; distributor Advanced Solution

Short Interest History

Last 12 Months
Loading short interest data...

Days to Cover History

Last 12 Months
Loading days to cover data...

Frequently Asked Questions

What is the current stock price of Biolargo (BLGO)?

The current stock price of Biolargo (BLGO) is $0.1843 as of December 31, 2025.

What is the market cap of Biolargo (BLGO)?

The market cap of Biolargo (BLGO) is approximately 71.1M. Learn more about what market capitalization means .

What is the revenue (TTM) of Biolargo (BLGO) stock?

The trailing twelve months (TTM) revenue of Biolargo (BLGO) is $776.

What is the operating cash flow of Biolargo (BLGO)?

The operating cash flow of Biolargo (BLGO) is $6,707. Learn about cash flow.

What is the operating margin of Biolargo (BLGO)?

The operating profit margin of Biolargo (BLGO) is 9.25%. Learn about operating margins.

What is the gross margin of Biolargo (BLGO)?

The gross profit margin of Biolargo (BLGO) is 0.48%. Learn about gross margins.

What is the current ratio of Biolargo (BLGO)?

The current ratio of Biolargo (BLGO) is 1.67, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.

What is the gross profit of Biolargo (BLGO)?

The gross profit of Biolargo (BLGO) is $372 on a trailing twelve months (TTM) basis.

What is the operating income of Biolargo (BLGO)?

The operating income of Biolargo (BLGO) is $7,180. Learn about operating income.

What does BioLargo do?

BioLargo develops and commercializes environmental technologies for PFAS water treatment, advanced water and wastewater purification, energy storage battery systems, medical infection control products, and odor elimination solutions. The company operates through multiple business segments serving municipal, industrial, healthcare, and consumer markets.

What is BioLargo's AEC technology?

The BioLargo AEC (Aqueous Electrostatic Concentrator) is a water treatment system that uses electrolysis to extract PFAS molecules from contaminated water and deposit them onto proprietary membranes. The technology operates with minimal electricity and no input chemistry, producing less contaminated waste than traditional carbon filtration systems.

What is Cellinity battery technology?

Cellinity is BioLargo's liquid-sodium battery technology designed for long-duration energy storage. Unlike lithium batteries, Cellinity systems avoid thermal runaway risks and don't require rare earth minerals or toxic chemicals. The batteries target applications in grid stabilization, renewable energy storage, data centers, and electric vehicle charging stations.

What industries does BioLargo serve?

BioLargo serves municipal water utilities, industrial manufacturers requiring wastewater treatment and odor control, healthcare facilities using infection control technologies, energy companies needing storage solutions, and consumer markets through retail pet care products. The company's technologies address environmental compliance and operational challenges across these sectors.

How does BioLargo commercialize its technologies?

BioLargo employs a business model that involves inventing or acquiring technologies, developing them into products, and extending commercial reach through licensing agreements and strategic partnerships. For battery technology, the company contemplates joint venture arrangements where partners build manufacturing facilities in exchange for licensing rights and pay ongoing royalties.